Stress peptides sensitize fear circuitry to promote passive coping.


Journal

Molecular psychiatry
ISSN: 1476-5578
Titre abrégé: Mol Psychiatry
Pays: England
ID NLM: 9607835

Informations de publication

Date de publication:
02 2020
Historique:
received: 29 11 2016
accepted: 10 04 2018
revised: 04 04 2018
pubmed: 16 6 2018
medline: 15 12 2020
entrez: 16 6 2018
Statut: ppublish

Résumé

Survival relies on optimizing behavioral responses through experience. Animals often react to acute stress by switching to passive behavioral responses when coping with environmental challenge. Despite recent advances in dissecting mammalian circuitry for Pavlovian fear, the neuronal basis underlying this form of non-Pavlovian anxiety-related behavioral plasticity remains poorly understood. Here, we report that aversive experience recruits the posterior paraventricular thalamus (PVT) and corticotropin-releasing hormone (CRH) and sensitizes a Pavlovian fear circuit to promote passive responding. Site-specific lesions and optogenetic manipulations reveal that PVT-to-central amygdala (CE) projections activate anxiogenic neuronal populations in the CE that release local CRH in response to acute stress. CRH potentiates basolateral (BLA)-CE connectivity and antagonizes inhibitory gating of CE output, a mechanism linked to Pavlovian fear, to facilitate the switch from active to passive behavior. Thus, PVT-amygdala fear circuitry uses inhibitory gating in the CE as a shared dynamic motif, but relies on different cellular mechanisms (postsynaptic long-term potentiation vs. presynaptic facilitation), to multiplex active/passive response bias in Pavlovian and non-Pavlovian behavioral plasticity. These results establish a framework promoting stress-induced passive responding, which might contribute to passive emotional coping seen in human fear- and anxiety-related disorders.

Identifiants

pubmed: 29904149
doi: 10.1038/s41380-018-0089-2
pii: 10.1038/s41380-018-0089-2
pmc: PMC6169733
mid: EMS77086
doi:

Substances chimiques

Corticotropin-Releasing Hormone 9015-71-8

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

428-441

Subventions

Organisme : European Research Council
ID : 311701
Pays : International

Références

Keay KA, Bandler R, Parallel circuits mediating distinct emotional coping reactions to different types of stress. Neurosci Biobehav Rev. 2001;25:669–78.
doi: 10.1016/S0149-7634(01)00049-5 pubmed: 11801292 pmcid: 11801292
Cannon WB, Bodily changes in pain, hunger, fear, and rage: an account of recent researches into the function of emotional excitement. New York: D. Appleton. 1916.
Shalev A, Liberzon I, Marmar C, Post-traumatic stress disorder. N Engl J Med. 2017;376:2459–69.
doi: 10.1056/NEJMra1612499 pubmed: 28636846 pmcid: 28636846
Wilensky AE, Schafe GE, Kristensen MP, LeDoux JE, Rethinking the fear circuit: the central nucleus of the amygdala is required for the acquisition, consolidation, and expression of Pavlovian fear conditioning. J Neurosci: Off J Soc Neurosci. 2006;26:12387–96.
doi: 10.1523/JNEUROSCI.4316-06.2006
LeDoux JE, Emotion circuits in the brain. Annu Rev Neurosci. 2000;23:155–84.
doi: 10.1146/annurev.neuro.23.1.155 pubmed: 10845062 pmcid: 10845062
Duvarci S, Pare D, Amygdala microcircuits controlling learned fear. Neuron. 2014;82:966–80.
doi: 10.1016/j.neuron.2014.04.042 pubmed: 24908482 pmcid: 24908482
Li H, Penzo MA, Taniguchi H, Kopec CD, Huang ZJ, Li B, Experience-dependent modification of a central amygdala fear circuit. Nat Neurosci. 2013;16:332–9.
doi: 10.1038/nn.3322 pubmed: 23354330 pmcid: 23354330
Rumpel S, LeDoux J, Zador A, Malinow R, Postsynaptic receptor trafficking underlying a form of associative learning. Science. 2005;308:83–8.
doi: 10.1126/science.1103944 pubmed: 15746389 pmcid: 15746389
Sanford CA, Soden ME, Baird MA, Miller SM, Schulkin J, Palmiter RD, et al. A central amygdala CRF circuit facilitates learning about weak threats. Neuron. 2017;93:164–78.
doi: 10.1016/j.neuron.2016.11.034 pubmed: 28017470 pmcid: 28017470
Ciocchi S, Herry C, Grenier F, Wolff SB, Letzkus JJ, Vlachos I, et al. Encoding of conditioned fear in central amygdala inhibitory circuits. Nature. 2010;468:277–82.
doi: 10.1038/nature09559 pubmed: 21068837 pmcid: 21068837
Haubensak W, Kunwar PS, Cai H, Ciocchi S, Wall NR, Ponnusamy R, et al. Genetic dissection of an amygdala microcircuit that gates conditioned fear. Nature. 2010;468:270–6.
doi: 10.1038/nature09553 pubmed: 21068836 pmcid: 21068836
Gozzi A, Jain A, Giovanelli A, Bertollini C, Crestan V, Schwarz AJ, et al. A neural switch for active and passive fear. Neuron. 2010;67:656–66.
doi: 10.1016/j.neuron.2010.07.008 pubmed: 20797541 pmcid: 20797541
Fadok JP, Krabbe S, Markovic M, Courtin J, Xu C, Massi L, et al. A competitive inhibitory circuit for selection of active and passive fear responses. Nature. 2017;542:96–100.
doi: 10.1038/nature21047 pubmed: 28117439 pmcid: 28117439
Kim J, Zhang X, Muralidhar S, LeBlanc SA, Tonegawa S, Basolateral to central amygdala neural circuits for appetitive behaviors. Neuron. 2017;93:1464–79e5.
doi: 10.1016/j.neuron.2017.02.034 pubmed: 28334609 pmcid: 28334609
Yu K, Ahrens S, Zhang X, Schiff H, Ramakrishnan C, Fenno L, et al. The central amygdala controls learning in the lateral amygdala. Nat Neurosci. 2017;20:1680–5.
doi: 10.1038/s41593-017-0009-9 pubmed: 29184202 pmcid: 29184202
Janak PH, Tye KM, From circuits to behaviour in the amygdala. Nature. 2015;517:284–92.
doi: 10.1038/nature14188 pubmed: 4565157 pmcid: 4565157
Mongeau R, Miller GA, Chiang E, Anderson DJ, Neural correlates of competing fear behaviors evoked by an innately aversive stimulus. J Neurosci: Off J Soc Neurosci. 2003;23:3855–68.
doi: 10.1523/JNEUROSCI.23-09-03855.2003
Steimer T, The biology of fear- and anxiety-related behaviors. Dialog Clin Neurosci. 2002;4:231–49.
Steenbergen HL, Farabollini F, Heinsbroek RP, Van de Poll NE, Sex-dependent effects of aversive stimulation on holeboard and elevated plus-maze behavior. Behav Brain Res. 1991;43:159–65.
doi: 10.1016/S0166-4328(05)80066-X pubmed: 1867757 pmcid: 1867757
Steenbergen HL, Heinsbroek RP, Van Hest A, Van de Poll NE, Sex-dependent effects of inescapable shock administration on shuttlebox-escape performance and elevated plus-maze behavior. Physiol Behav. 1990;48:571–6.
doi: 10.1016/0031-9384(90)90302-K
Matheson K, Anisman H, Systems of coping associated with dysphoria, anxiety and depressive illness: a multivariate profile perspective. Stress. 2003;6:223–34.
doi: 10.1080/10253890310001594487
Amorapanth P, LeDoux JE, Nader K, Different lateral amygdala outputs mediate reactions and actions elicited by a fear-arousing stimulus. Nat Neurosci. 2000;3:74–9.
doi: 10.1038/71145
Yu K, Garcia da Silva P, Albeanu DF, Li B, Central amygdala somatostatin neurons gate passive and active defensive behaviors. J Neurosci: Off J Soc Neurosci. 2016;36:6488–96.
doi: 10.1523/JNEUROSCI.4419-15.2016
Kirouac GJ, Placing the paraventricular nucleus of the thalamus within the brain circuits that control behavior. Neurosci Biobehav Rev. 2015;56:315–29.
doi: 10.1016/j.neubiorev.2015.08.005
Dong X, Li S, Kirouac GJ, Collateralization of projections from the paraventricular nucleus of the thalamus to the nucleus accumbens, bed nucleus of the stria terminalis, and central nucleus of the amygdala. Brain Struct Funct. 2017;222:3927–43.
doi: 10.1007/s00429-017-1445-8
Li Y, Dong X, Li S, Kirouac GJ, Lesions of the posterior paraventricular nucleus of the thalamus attenuate fear expression. Front Behav Neurosci. 2014;8:94
pubmed: 3960725 pmcid: 3960725
Li S, Kirouac GJ, Projections from the paraventricular nucleus of the thalamus to the forebrain, with special emphasis on the extended amygdala. J Comp Neurol. 2008;506:263–87.
doi: 10.1002/cne.21502
Do-Monte FH, Quinones-Laracuente K, Quirk GJ, A temporal shift in the circuits mediating retrieval of fear memory. Nature. 2015;519:460–3.
doi: 10.1038/nature14030 pubmed: 4376623 pmcid: 4376623
Do-Monte FH, Minier-Toribio A, Quinones-Laracuente K, Medina-Colon EM, Quirk GJ, Thalamic regulation of sucrose seeking during unexpected reward omission. Neuron. 2017;94:388–400e4.
doi: 10.1016/j.neuron.2017.03.036 pubmed: 5484638 pmcid: 5484638
Vertes RP, Hoover WB, Projections of the paraventricular and paratenial nuclei of the dorsal midline thalamus in the rat. J Comp Neurol. 2008;508:212–37.
doi: 10.1002/cne.21679
Hsu DT, Price JL, Paraventricular thalamic nucleus: subcortical connections and innervation by serotonin, orexin, and corticotropin-releasing hormone in macaque monkeys. J Comp Neurol. 2009;512:825–48.
doi: 10.1002/cne.21934 pubmed: 19085970 pmcid: 19085970
Li S, Kirouac GJ, Sources of inputs to the anterior and posterior aspects of the paraventricular nucleus of the thalamus. Brain Struct Funct. 2012;217:257–73.
doi: 10.1007/s00429-011-0360-7
Sharp FR, Sagar SM, Hicks K, Lowenstein D, Hisanaga K, c-fos mRNA, Fos, and Fos-related antigen induction by hypertonic saline and stres. J Neurosci: Off J Soc Neurosci. 1991;11:2321–31.
doi: 10.1523/JNEUROSCI.11-08-02321.1991
Bhatnagar S, Dallman M, Neuroanatomical basis for facilitation of hypothalamic-pituitary-adrenal responses to a novel stressor after chronic stress. Neuroscience. 1998;84:1025–39.
doi: 10.1016/S0306-4522(97)00577-0
Bubser M, Deutch AY, Stress induces Fos expression in neurons of the thalamic paraventricular nucleus that innervate limbic forebrain sites. Synapse. 1999;32:13–22.
doi: 10.1002/(SICI)1098-2396(199904)32:1<13::AID-SYN2>3.0.CO;2-R
Penzo MA, Robert V, Tucciarone J, De Bundel D, Wang M, Van Aelst L, et al. The paraventricular thalamus controls a central amygdala fear circuit. Nature. 2015;519: 455–459.
Tye KM, Prakash R, Kim SY, Fenno LE, Grosenick L, Zarabi H, et al. Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature. 2011;471:358–62.
doi: 10.1038/nature09820 pubmed: 21389985 pmcid: 21389985
Gilpin NW, Herman MA, Roberto M, The central amygdala as an integrative hub for anxiety and alcohol use disorders. Biol Psychiatry. 2015;77:859–69.
doi: 10.1016/j.biopsych.2014.09.008
Calhoon GG, Tye KM, Resolving the neural circuits of anxiety. Nat Neurosci. 2015;18:1394–404.
doi: 10.1038/nn.4101 pubmed: 26404714 pmcid: 26404714
Silberman Y, Winder DG, Corticotropin releasing factor and catecholamines enhance glutamatergic neurotransmission in the lateral subdivision of the central amygdala. Neuropharmacology. 2013;70:316–23.
doi: 10.1016/j.neuropharm.2013.02.014 pubmed: 23470280 pmcid: 23470280
Davis M, Shi C, The extended amygdala: are the central nucleus of the amygdala and the bed nucleus of the stria terminalis differentially involved in fear versus anxiety?. Ann N Y Acad Sci. 1999;877:281–91.
doi: 10.1111/j.1749-6632.1999.tb09273.x pubmed: 10415655 pmcid: 10415655
Muller MB, Zimmermann S, Sillaber I, Hagemeyer TP, Deussing JM, Timpl P, et al. Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat Neurosci. 2003;6:1100–7.
doi: 10.1038/nn1123 pubmed: 12973355 pmcid: 12973355
Holsboer F, CRHR1 antagonists as novel treatment strategies. CNS Spectr. 2001;6:590–4.
doi: 10.1017/S1092852900002133 pubmed: 15573022 pmcid: 15573022
Kuhne C, Puk O, Graw J, Hrabe de Angelis M, Schutz G, Wurst W, et al. Visualizing corticotropin-releasing hormone receptor type 1 expression and neuronal connectivities in the mouse using a novel multifunctional allele. J Comp Neurol. 2012;520:3150–80.
doi: 10.1002/cne.23082 pubmed: 22886732 pmcid: 22886732
Zweifel LS, Fadok JP, Argilli E, Garelick MG, Jones GL, Dickerson TM, et al. Activation of dopamine neurons is critical for aversive conditioning and prevention of generalized anxiety. Nat Neurosci. 2011;14:620–6.
doi: 10.1038/nn.2808 pubmed: 21499253 pmcid: 21499253
Li XB, Inoue T, Nakagawa S, Koyama T, Effect of mediodorsal thalamic nucleus lesion on contextual fear conditioning in rats. Brain Res. 2004;1008:261–72.
doi: 10.1016/j.brainres.2004.02.038 pubmed: 15145764 pmcid: 15145764
Zhu L, Wu L, Yu B, Liu X, The participation of a neurocircuit from the paraventricular thalamus to amygdala in the depressive like behavior. Neurosci Lett. 2011;488:81–6.
doi: 10.1016/j.neulet.2010.11.007 pubmed: 21073922 pmcid: 21073922
Zorrilla EP, Valdez GR, Nozulak J, Koob GF, Markou A, Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat. Brain Res. 2002;952:188–99.
doi: 10.1016/S0006-8993(02)03189-X pubmed: 12376179 pmcid: 12376179
McCall JG, Al-Hasani R, Siuda ER, Hong DY, Norris AJ, Ford CP, et al. CRH engagement of the locus coeruleus noradrenergic system mediates stress-induced anxiety. Neuron. 2015;87:605–20.
doi: 10.1016/j.neuron.2015.07.002 pubmed: 26212712 pmcid: 26212712
Duvarci S, Popa D, Pare D, Central amygdala activity during fear conditioning. J Neurosci. 2011;31:289–94.
doi: 10.1523/JNEUROSCI.4985-10.2011 pubmed: 3080118 pmcid: 3080118
Darvas M, Fadok JP, Palmiter RD, Requirement of dopamine signaling in the amygdala and striatum for learning and maintenance of a conditioned avoidance response. Learn Mem. 2011;18:136–43.
doi: 10.1101/lm.2041211 pubmed: 3056517 pmcid: 3056517
Shors TJ, Learning during stressful times. Learn Mem. 2004;11:137–44.
doi: 10.1101/lm.66604 pubmed: 3364672 pmcid: 3364672
Shors TJ, Weiss C, Thompson RF, Stress-induced facilitation of classical conditioning. Science. 1992;257:537–9.
doi: 10.1126/science.1636089
Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB, Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52:1048–60.
doi: 10.1001/archpsyc.1995.03950240066012 pubmed: 7492257 pmcid: 7492257
DSM5_Task_Force. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed Washington, DC: American Psychiatric Association; 2013. xliv, 947pp.
Refojo D, Schweizer M, Kuehne C, Ehrenberg S, Thoeringer C, Vogl AM, et al. Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1. Science. 2011;333:1903–7.
doi: 10.1126/science.1202107 pubmed: 21885734 pmcid: 21885734
Kehne JH, Cain CK, Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: evidence from animal models. Pharmacol Ther. 2010;128:460–87.
doi: 10.1016/j.pharmthera.2010.08.011 pubmed: 20826181 pmcid: 20826181

Auteurs

Pinelopi Pliota (P)

Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Dr. Bohr Gasse 7, 1030, Vienna, Austria.

Vincent Böhm (V)

Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Dr. Bohr Gasse 7, 1030, Vienna, Austria.

Florian Grössl (F)

Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Dr. Bohr Gasse 7, 1030, Vienna, Austria.

Johannes Griessner (J)

Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Dr. Bohr Gasse 7, 1030, Vienna, Austria.

Ornella Valenti (O)

Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Dr. Bohr Gasse 7, 1030, Vienna, Austria.
Division of Neurophysiology and Neuropharmacology, Centre for Physiology and Pharmacology, Medical Univ. Vienna, Schwarzspanierstrasse 17, 1090, Vienna, Austria.

Klaus Kraitsy (K)

Preclinical Phenotyping, Vienna Biocenter (VBC), Dr. Bohr Gasse 3, 1030, Vienna, Austria.

Joanna Kaczanowska (J)

Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Dr. Bohr Gasse 7, 1030, Vienna, Austria.

Manuel Pasieka (M)

Bioinformatics and Scientific Computing, Vienna Biocenter (VBC), Dr. Bohr Gasse 3, 1030, Vienna, Austria.

Thomas Lendl (T)

Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Dr. Bohr Gasse 7, 1030, Vienna, Austria.

Jan M Deussing (JM)

Department of Stress Neurobiology & Neurogenetics, Max Planck Institute of Psychiatry, 80804, Munich, Germany.

Wulf Haubensak (W)

Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Dr. Bohr Gasse 7, 1030, Vienna, Austria. wulf.haubensak@imp.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH